Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

497

Participants

Timeline

Start Date

September 22, 2008

Primary Completion Date

December 29, 2009

Study Completion Date

December 29, 2009

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Dapagliflozin

Tablets, Oral, Once Daily, Up to 24 weeks

DRUG

Placebo

Tablets, Oral, Once Daily, Up to 24 weeks

Trial Locations (62)

1501

Local Institution, Benoni

1818

Local Institution, Soweto

7505

Local Institution, Tygerberg

7646

Local Institution, Paarl

11800

Local Institution, Df

13210

Internist Associates Of Central New York, Syracuse

14224

Southgate Medical Group, West Seneca

28557

Down East Medical Associates, Pa, Morehead City

29687

Southeastern Research Associates, Inc., Taylors

30076

Endocrine Research Solutions, Inc., Roswell

32205

Westside Center For Clinical Research, Jacksonville

32446

Panhandle Family Care Associates, Marianna

32701

Central Florida Clinical Trials, Inc., Altamonte Springs

34000

Local Institution, Durango

39038

Belzoni Clinical Research, Belzoni

44319

James J. Brown, Md, Akron

44670

Local Institution, Guadalajara

64060

Local Institution, Monterrey

73170

Integris Family Care South, Oklahoma City

78224

Abbott Clinical Research Group, Inc, San Antonio

80634

Family Physicians Of Greeley, Greeley

84047

Avastra Clinical Trials, Midvale

84102

Optimum Clinical Research, Inc., Salt Lake City

85051

43rd Medical Associates, P.C., Phoenix

85282

Clinical Research Advantage, Inc., Tempe

85340

Dedicated Clinical Research, Litchfield Park

90717

Marina Raikhel, Md, Faafp, Lomita

91910

Local Institution, Veracruz

92780

Orange County Research Center, Tustin

93720

Valley Research, Fresno

95032

Richard S. Cherlin, Md, Los Gatos

97070

Local Institution, Mérida

98502

Capital Clinical Research Center, Olympia

99216

Stephen G. Danley, Do, Spokane

191015

Local Institution, Saint Petersburg

195112

Local Institution, Saint Petersburg

195257

Local Institution, Saint Petersburg

197022

Local Institution, Saint Petersburg

197341

Local Institution, Saint Petersburg

214018

Local Institution, Smolensk

302001

Local Institution, Jaipur

302016

Local Institution, Jaipur

305035

Local Institution, Kursk

410012

Local Institution, Saratov

06320

Coastal Connecticut Research, Llc, New London

08690

R-Research, Hamilton

T3C 3P1

Local Institution, Calgary

V3K 3V9

Local Institution, Coquitlam

R3E 3P4

Local Institution, Winnipeg

E2A 4X7

Local Institution, Bathurst

L1S 7J5

Local Institution, Ajax

M9W 4L6

Local Institution, Toronto

N2T 2Z6

Local Institution, Waterloo

J2B 7T1

Local Institution, Drummondville

G2E 2X1

Local Institution, L'Ancienne-Lorette

H1S 3A9

Local Institution, Saint-Léonard

380 015

Local Institution, Ahmedabad

560 043

Local Institution, Bangalore

560 052

Local Institution, Bangalore

06700

Local Institution, Mexico City

00716

Local Institution, Ponce

00717

Local Institution, Ponce

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

AstraZeneca

INDUSTRY